AbbVie Inc. — Director's Dealing 2018

Oct 24, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2018-10-16

Reporting Person: Durkin Brian L (VP, Controller)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, $0.01 par value	4251	Direct
Common stock, $0.01 par value	253	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option (right to buy)	$64.12	2026-07-24	Common stock (5240)		Direct
Option (right to buy)	$61.36	2027-02-15	Common stock (7180)		Direct
Option (right to buy)	$114.36	2028-02-14	Common stock (3110)		Direct

Footnotes

F1: The reporting person disclaims beneficial ownership of all securities held by his spouse.

F2: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 1,747 shares on 7/25/2017 and as to 1,746 shares on 7/25/2018, and becomes exercisable as to 1,747 shares on 7/25/2019.

F3: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 2,394 shares on 2/16/2018, and becomes exercisable as to 2,393 shares on 2/16/2019 and as to 2,393 shares on 2/16/2020.

F4: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 1,037 shares on 02/15/2019, 1,036 shares on 02/15/2020, and 1,037 shares on 02/15/2021.